140 related articles for article (PubMed ID: 28574091)
1. Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5.
Song X; Lu LY; Passioura T; Suga H
Org Biomol Chem; 2017 Jun; 15(24):5155-5160. PubMed ID: 28574091
[TBL] [Abstract][Full Text] [Related]
2. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.
Schwarz TM; Edwards MR; Diederichs A; Alinger JB; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974555
[TBL] [Abstract][Full Text] [Related]
3. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1.
Xu W; Edwards MR; Borek DM; Feagins AR; Mittal A; Alinger JB; Berry KN; Yen B; Hamilton J; Brett TJ; Pappu RV; Leung DW; Basler CF; Amarasinghe GK
Cell Host Microbe; 2014 Aug; 16(2):187-200. PubMed ID: 25121748
[TBL] [Abstract][Full Text] [Related]
4. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.
Reid SP; Valmas C; Martinez O; Sanchez FM; Basler CF
J Virol; 2007 Dec; 81(24):13469-77. PubMed ID: 17928350
[TBL] [Abstract][Full Text] [Related]
5. An all-atom molecular dynamics study of the anti-interferon signaling of Ebola virus: interaction mechanisms of EBOV VP24 binding to Karyopherin alpha5.
Ding JN; Zhang YJ; Zhong H; Ao CC; Li J; Han JG
Mol Biosyst; 2017 May; 13(5):1031-1045. PubMed ID: 28418440
[TBL] [Abstract][Full Text] [Related]
6. Investigating Ebola virus pathogenicity using molecular dynamics.
Pappalardo M; Collu F; Macpherson J; Michaelis M; Fraternali F; Wass MN
BMC Genomics; 2017 Aug; 18(Suppl 5):566. PubMed ID: 28812539
[TBL] [Abstract][Full Text] [Related]
7. Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.
Ramanathan P; Tigabu B; Santos RI; Ilinykh PA; Kuzmina N; Vogel OA; Thakur N; Ahmed H; Wu C; Amarasinghe GK; Basler CF; Bukreyev A
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243162
[TBL] [Abstract][Full Text] [Related]
8. In Silico Study of Plant Polyphenols' Interactions with VP24-Ebola Virus Membrane-associated Protein.
Pleško S; Volk H; Lukšič M; Podlipnik Č
Acta Chim Slov; 2015; 62(3):555-64. PubMed ID: 26454589
[TBL] [Abstract][Full Text] [Related]
9. The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.
Zhang AP; Bornholdt ZA; Liu T; Abelson DM; Lee DE; Li S; Woods VL; Saphire EO
PLoS Pathog; 2012 Feb; 8(2):e1002550. PubMed ID: 22383882
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the Ebola Virus VP24 Protein by SUMO.
Vidal S; El Motiam A; Seoane R; Preitakaite V; Bouzaher YH; Gómez-Medina S; San Martín C; Rodríguez D; Rejas MT; Baz-Martínez M; Barrio R; Sutherland JD; Rodríguez MS; Muñoz-Fontela C; Rivas C
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597768
[TBL] [Abstract][Full Text] [Related]
11. The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import.
Shabman RS; Gulcicek EE; Stone KL; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S904-10. PubMed ID: 21987768
[TBL] [Abstract][Full Text] [Related]
12. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.
Reid SP; Leung LW; Hartman AL; Martinez O; Shaw ML; Carbonnelle C; Volchkov VE; Nichol ST; Basler CF
J Virol; 2006 Jun; 80(11):5156-67. PubMed ID: 16698996
[TBL] [Abstract][Full Text] [Related]
13. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
14. Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1.
Tanaka K; Kasahara Y; Miyamoto Y; Okuda T; Kasai T; Onodera K; Kuwahara M; Oka M; Yoneda Y; Obika S
Org Biomol Chem; 2018 Jun; 16(24):4456-4463. PubMed ID: 29850750
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
16. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.
Mateo M; Reid SP; Leung LW; Basler CF; Volchkov VE
J Virol; 2010 Jan; 84(2):1169-75. PubMed ID: 19889762
[TBL] [Abstract][Full Text] [Related]
17. Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging.
Banadyga L; Hoenen T; Ambroggio X; Dunham E; Groseth A; Ebihara H
Sci Rep; 2017 Aug; 7(1):7698. PubMed ID: 28794491
[TBL] [Abstract][Full Text] [Related]
18. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.
Feagins AR; Basler CF
Virology; 2015 Nov; 485():145-52. PubMed ID: 26255028
[TBL] [Abstract][Full Text] [Related]
19. In vitro selection of anti-Akt2 thioether-macrocyclic peptides leading to isoform-selective inhibitors.
Hayashi Y; Morimoto J; Suga H
ACS Chem Biol; 2012 Mar; 7(3):607-13. PubMed ID: 22273180
[TBL] [Abstract][Full Text] [Related]
20. Ebolavirus interferon antagonists-protein interaction perspectives to combat pathogenesis.
Banerjee A; Pal A; Pal D; Mitra P
Brief Funct Genomics; 2018 Nov; 17(6):392-401. PubMed ID: 29140409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]